Recently, researchers in Australia tested baricitinib, a drug used for rheumatoid arthritis, in people newly diagnosed with Type‑1 diabetes, showing promising results for early intervention.

Know the key differences between these FDA-approved diabetes and weight loss drugs. Learn about benefits, side effects, dosage, and which may be right for you.

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

Weight-loss surgery may provide stronger, long-term benefits than GLP-1 medications for people with obesity and diabetes. Experts say it reduces the risks of heart disease, kidney failure, and ...

Adverse cardiovascular outcomes and mortality risks were higher among patients with type 1 diabetes relative to type 2 diabetes.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

If approved, Awiqli would become the first once-weekly basal insulin available in the United States for adults with Type 2 ...

Researchers writing in The Lancet review breakthroughs in type 1 diabetes treatment, from immunotherapies that delay onset to ...

HealthDay News — Smoking increases the risk for type 2 diabetes across all disease subtypes, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, ...